Cargando…

Stem Cell Transplantation

Hematopoietic cell transplantation (HCT) is associated with profound compromises in host defenses. The patterns of immune compromise change over time. Infections are an important cause of serious morbidity and pose substantial threats to life. Thus, the challenges of infection facing the transplant...

Descripción completa

Detalles Bibliográficos
Autor principal: Wingard, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121531/
http://dx.doi.org/10.1007/978-1-59745-415-5_8
_version_ 1783515223236280320
author Wingard, John R.
author_facet Wingard, John R.
author_sort Wingard, John R.
collection PubMed
description Hematopoietic cell transplantation (HCT) is associated with profound compromises in host defenses. The patterns of immune compromise change over time. Infections are an important cause of serious morbidity and pose substantial threats to life. Thus, the challenges of infection facing the transplant clinician are both myriad and dynamic. Early after transplant, neutropenic infections are most important. Later herpesvirus and invasive fungal infections predominate. Even late after transplant, patients with chronic graft versus host disease remain susceptible to encapsulated bacterial, varicella zoster virus, and invasive fungal infections. Over time, with robust engraftment and control of GVHD, the risk of serious infections recedes with immune reconstitution.
format Online
Article
Text
id pubmed-7121531
institution National Center for Biotechnology Information
language English
publishDate 2009
record_format MEDLINE/PubMed
spelling pubmed-71215312020-04-06 Stem Cell Transplantation Wingard, John R. Managing Infections in Patients With Hematological Malignancies Article Hematopoietic cell transplantation (HCT) is associated with profound compromises in host defenses. The patterns of immune compromise change over time. Infections are an important cause of serious morbidity and pose substantial threats to life. Thus, the challenges of infection facing the transplant clinician are both myriad and dynamic. Early after transplant, neutropenic infections are most important. Later herpesvirus and invasive fungal infections predominate. Even late after transplant, patients with chronic graft versus host disease remain susceptible to encapsulated bacterial, varicella zoster virus, and invasive fungal infections. Over time, with robust engraftment and control of GVHD, the risk of serious infections recedes with immune reconstitution. 2009-08-31 /pmc/articles/PMC7121531/ http://dx.doi.org/10.1007/978-1-59745-415-5_8 Text en © Humana Press 2009 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Wingard, John R.
Stem Cell Transplantation
title Stem Cell Transplantation
title_full Stem Cell Transplantation
title_fullStr Stem Cell Transplantation
title_full_unstemmed Stem Cell Transplantation
title_short Stem Cell Transplantation
title_sort stem cell transplantation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121531/
http://dx.doi.org/10.1007/978-1-59745-415-5_8
work_keys_str_mv AT wingardjohnr stemcelltransplantation